Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
They redirected clinical questions to the in-app care team
E., & Duncan, G
For weight management, Zepbound is indicated for adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity, as an adjunct to reduced-calorie diet and increased physical activity
Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare providers discretion
New York Medicaid covers diabetes GLP-1s (including Mounjaro) with PA at nominal cost-share, but does NOT cover weight-loss GLP-1s EmblemHealth's large NYC Medicaid population faces this restriction
Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP/GLP-1 receptor agonist that significantly slows gastric emptying
US$ 22.64
US$ 29.48
US$ 20.57
US$ 24.30
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 25.77
US$ 22.43
